Academic head of project management: Zoltán Szekanecz
- Title of project: GLORIA - A további alacsony dózisú glükokortikoid hatékonyságának és biztonságosságának összehasonlítása a reumatoid artritiszben szenvedő idős betegek kezelési stratégiáiban
- Type of grant: H2020
- Description: The objective of the project is to prove that the complementation of the current therapy treating rheumatism with chronic low-dose glucocorticoids (GC) is extremely cost effective and safe in the case of elderly patients with rheumatoid arthritis.
- The duration of the project: September 1, 2015 – August 31, 2020
- Actual total cost: 203.095 (EUR)
- Type of research: Experimental
- Consortium details:
- Lead applicant: Stichting VU-VUmc
- Consortium partner:
- UNIVERSITA DEGLI STRUDI DI GENOVA (UNIGE)
- Stichting Tools
- BLUEPHARMA - INDUSTRIA FARMACEUTICASA (BLUEPHARMA)
- ASSIGN BENELUX DEVELOPMENT BV (ABD)
- CLINQUEST SERVICES BV (Clinquest Services B.V.)
- QOLPAC BV (QOLPAC BV)
- UNIVERSITATEA DE MEDICINA SI FARMACIE'CAROL DAVILA' DIN BUCURESTI
- NARODNY USTAV REUMATICKYCH CHOROB-NURCH NIRD NATIONAL INSTITUTE OF RHEUMATIC DISEASES (NURCH NIRD)
- CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E (CHUC, E.P.E)
- Charité - Universitätsmedizin Berlin
- Debreceni Egyetem
Legutóbb frissítve:
2021. 08. 16. 11:01